Immunomonitoring to Predict Clinical Outcomes of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Emerging role of immunomonitoring to predict the clinical outcome of patient with Malignant Pleural Mesothelioma treated with radical radiation therapy
Int. J. Radiat. Oncol. Biol. Phys 2022 Oct 03;[EPub Ahead of Print], M Cangemi, M Montico, M Trovo, E Minatel, ED Gregorio, G Corona, F Giordari, E Comaro, F Colizzi, L Baboçi, A Steffan, A Revelant, E MuraroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.